Despite continued efforts to develop new therapies for glioblastoma, none have been able to improve how long patients live appreciably. Despite some setbacks, researchers are hopeful that immunotherapy might be able to succeed where other therapies have not.
https://ift.tt/2IYw1ar
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου